Our data indicate a high prevalence of CAM usage (94.4%) among cancer patients (
10,
14-
16). Considering plenty of previous studies, the prevalence of CAM use is usually more than 40%. The frequency of CAM use in this study was higher than that reported in the U.S. (53.7%), Australia and Malaysia (64%), Japan (44.6%), and Turkey (57%) (
17-
19). The socio-demographic characteristics of the participants used CAM in this study were somehow comparable to similar previous studies with female subjects more inclined to using CAM therapies (
10,
14,
20-
22). However, the annual household incomes of our participants were low (
15,
16,
23,
24). It seems that health insurance programs in the country increasingly cover CAM services and providers, much like the case in other developed nations (
25,
26).
Although our patients used CAM for a variety of reasons, they mostly agreed to use these therapies as their responsible physicians recommended to do so. It seems that our adult oncologists are familiar with this growing field of medicine and believe in their efficacy as an adjunct therapy.
It has been shown that prayer is the most common CAM therapy being used in the general population of the United State (
27) and one of the most frequently reported by oncology patients (
28-
30). Wells et al. reported that 34.9% of cancer patients used prayer for resuming their health and it was the most commonly used CAM (
31). Spiritual healing in Montazeri et al. study was the most popular CAM modality used by almost 80% of Iranian cancer patients (
10). Similarly, in our study, prayer was reported as the most common CAM therapy employed by CAM users in cancer patients.
Lengacher et al. found that prayer, massage, herbal products, and meditation were the CAM therapies rated as being the most effective in women with breast cancer (
28). In our study, praying, herbal products (Mint and Garlic), multivitamins and vitamin C were the most preferable CAM.
Our study faced some limitations. A potential bias is that our patients were selected from a referral and tertiary hospital. Moreover, our sample size was too small to generalize our results to all Iranian cancer patients. Despite these limitations, the frequency of CAM usage in our study was comparable to other regional and global studies.
In conclusion, we determined the most frequent types of CAM in Iranian patients with cancer as well as reasons behind this use, satisfaction and information about complementary and alternative therapy. Based on our results CAM is increasingly being used in cancer patients. Due to potential side effects and interactions these products may have with the mainstream treatments, it is crucial for oncologists to be aware of CAM use among their patients. Since the patients mostly trust their physicians, it is a good opportunity to guide and encourage them to use appropriate CAM while monitoring the expected adverse reactions.